Mindfulness-oriented recovery enhancement ameliorates the impact of pain on self-reported psychological and physical function among opioid-using chronic pain patients.
Eric L Garland, Elizabeth A. Thomas, Matthew O Howard
Journal of Pain and Symptom Management April 26, 2014 DOI: 10.1016/j.jpainsymman.2014.03.006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pilot randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 115 |
| Population | Chronic pain patients; mean age 48 ± 14 years; 68% female |
| Interventions | Mindfulness-Oriented Recovery Enhancement (MORE) support group |
| Duration | Eight weeks of treatment; three-month follow-up |
| Measures | Brief Pain Inventory |
| Topics | Meditation |
| Keywords | Humans Analgesics, opioid Pain measurement Treatment outcome Multivariate analysis Follow-up studies Pilot projects Quality of life Middle aged Female Self report Chronic pain Function Impairment |
| Key findings | MORE produced significantly greater reductions than a support group in pain-related functional interference across all Brief Pain Inventory domains at post-treatment, with effects largely maintained at three months; however, general activity and walking ability were no longer significant at follow-up, suggesting more durable effects for psychological function. |
Abstract
Context: Chronic pain impacts one-third of the U.S. population, and its effects are debilitating for individuals and costly to the medical system. Although opioids are commonly prescribed to address chronic pain, they confer risk for misuse and addiction in some patients and may not fully restore life function-particularly with regard to psychosocial factors. Because of the multiplicity of impacts that chronic pain may have on daily functioning, broad-spectrum behavioral interventions are needed.
Objectives: The purpose of this study was to conduct follow-up analyses from a pilot randomized controlled trial of Mindfulness-Oriented Recovery Enhancement (MORE) to assess specific effects of MORE on various biopsychosocial aspects of pain-related impairment.
Methods: Chronic pain patients (N = 115; mean age, 48 ± 14 years; 68% female) were randomly assigned to either eight weeks of MORE or a support group. Domains of pain-related functional interference were measured with the Brief Pain Inventory at pre- and post-treatment and at a three-month follow-up. Treatment effects were analyzed with multivariate intention-to-treat models.
Results: MORE participants reported significantly greater reductions in functional interference than support group participants at post-treatment across all domains, including general activity, mood, walking ability, normal work, relationships, sleep, and enjoyment of life. These effects were largely maintained by the three-month follow-up; however, general activity level and walking ability were no longer significant, indicating differential long-term effects between physiological and psychological functioning.
Conclusion: Findings demonstrate preliminary efficacy of MORE as a treatment for pain-related functional impairments and suggest that effects may be more pronounced and durable for aspects of psychological function.
Comparable studies
Other randomized controlled trials on meditation, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment | 2003 | Randomized controlled trial | n = 41 |
| Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients | 2000 | Randomized controlled trial | n = 145 |
| Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults | 2008 | Randomized controlled trial | n = 139 |
| Short-term meditation training improves attention and self-regulation Undergraduate Chinese students | 2007 | Randomized controlled trial | n = 40 |
| Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients | 2004 | Randomized controlled trial | n = 73 |
Citations in the library
Cited by 11
- Mindfulness Meditation and Psychopathology Annual Review of Clinical Psychology December 11, 2018
- Virtually delivered Mindfulness-Oriented Recovery Enhancement (MORE) reduces daily pain intensity in patients with lumbosacral radiculopathy: a randomized controlled trial. PAIN Reports April 1, 2024
- What can we learn from randomized clinical trials about the construct validity of self-report measures of mindfulness? A meta-analysis June 4, 2019
- "Noticing the Way that I'm Noticing Pain": A Qualitative Analysis of Therapeutic Progression in Mindfulness-Oriented Recovery Enhancement for Patients with Lumbosacral Radicular Pain. Mindfulness 2026
- A Systematic Review of the Adherence to Home-Practice Meditation Exercises in Patients with Chronic Pain. International Journal of Environmental Research and Public Health March 2, 2023
and 6 more in the library
Cites 10
- Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. Journal of Consulting and Clinical Psychology February 3, 2014
- Mindfulness-Oriented Recovery Enhancement Reduces Pain Attentional Bias in Chronic Pain Patients Psychotherapy and Psychosomatics 2013
- Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. The American journal of gastroenterology September 2011
- Upward spirals of positive emotions counter downward spirals of negativity: insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathology. Clinical Psychology Review November 1, 2010
- Mindfulness training modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: results of a randomized controlled pilot trial. Journal of Psychoactive Drugs June 1, 2010
and 5 more in the library